Exactitude Consultancy Press Release: Global atherectomy devices market

The increasing prevalence of cardiovascular diseases is significant driver for the atherectomy devices market.

The increasing prevalence of cardiovascular diseases, such as peripheral artery disease (PAD) and coronary artery disease (CAD), serves as a significant driver for the Atherectomy Devices Market. Factors such as sedentary lifestyles, unhealthy dietary habits, and an aging population contribute to the growing number of patients requiring atherectomy procedures. The rise in cardiovascular diseases creates a higher demand for effective treatment options like atherectomy, which can remove plaque build-up and restore blood flow. The need to address the escalating burden of cardiovascular diseases worldwide fuels the adoption of atherectomy devices and drives market growth in this field.

Explore 188 Market Data Tables Spread Through Nearly 125 Pages and In-Depth Analysis on “Atherectomy Devices Market by Product (Directional, Rotational, Laser, Orbital), by End User (Hospitals, Surgical Centers, Ambulatory Care Centers, Research Laboratories, Academic Institutes), by Application (Peripheral Vascular, Cardiovascular, Neurovascular) and Region, Global Trends and Forecast from 2022 to 2029.”  For Table of Contents

Covid-19 pandemic had positive effect on atherectomy devices market growth.

The COVID-19 pandemic had a positive impact on the atherectomy devices market in several ways. Firstly, the increased focus on minimizing hospital stays and reducing transmission risk had led to a greater demand for minimally invasive procedures like atherectomy, which performed in outpatient settings. Secondly, the pandemic had raised awareness about the importance of maintaining cardiovascular health, leading to increased proactive measures for prevention and treatment, including atherectomy procedures. Thirdly, the accelerated adoption of telehealth and digital health solutions had created opportunities for atherectomy device manufacturers to develop innovative remote guidance and training tools. Fourthly, healthcare system adaptations prioritized efficient and cost-effective procedures like atherectomy to manage cardiovascular diseases. Lastly, the pandemic had highlighted the need for continuous research and development in atherectomy devices, driving advancements and improved patient outcomes.

The procedural complexity and learning curve associated with atherectomy procedures act as a restraint in the atherectomy devices market.

The procedural complexity and learning curve associated with atherectomy procedures act as a restraint in the market. Performing atherectomy procedures requires specialized skills and training due to the intricate nature of the procedures, including navigating complex anatomical structures and selecting appropriate devices and techniques. The learning curve for healthcare providers can be steep, potentially limiting the widespread adoption of atherectomy devices. The requirement for specialized expertise and training may create a barrier, especially in regions with limited access to training opportunities. Overcoming the procedural complexity and ensuring adequate training are crucial for broader acceptance and utilization of atherectomy devices.

The concept of personalized medicine and precision therapeutics presents an opportunity in the atherectomy devices market.

The concept of personalized medicine and precision therapeutics presents an opportunity in the atherectomy devices market. Tailoring atherectomy procedures to individual patient needs based on factors like plaque characteristics, anatomy, and comorbidities can enhance treatment outcomes. Developing devices and techniques that enable personalized approaches to atherectomy opens new avenues for growth and differentiation. Advancements in imaging technologies, data analytics, and predictive modelling can assist in patient selection and treatment planning. Embracing personalized medicine allows for more precise and targeted interventions, improving patient outcomes and satisfaction. Manufacturers investing in this area can gain a competitive edge and drive market growth.

In the atherectomy devices market, North America is predicted to hold the largest market share.

North America the is the dominant region in the atherectomy devices market. It boasts advanced healthcare infrastructure, a high prevalence of cardiovascular diseases, and favourable reimbursement policies. The well-established medical facilities and technologies in North America contribute to the adoption and utilization of atherectomy devices. The large patient population with conditions like peripheral artery disease (PAD) and coronary artery disease (CAD) further drives the demand for these devices in the region.

Atherectomy Devices Market Player

The atherectomy devices market key players includes Medtronic plc, Koninklijke Philips N.V., Boston Scientific Corporation, Cardiovascular Systems, Inc., Becton Dickinson and Company, AngioDynamics Inc., Rex medical, Nipro Corporation, Invamed medical, Avinger Inc.

August 2022: AngioDynamics, Inc. announced that the Auryon Atherectomy System has gained 510(k) clearance for an expanded indication that includes arterial thrombectomy.

June 2020: BD (Becton, Dickinson and Company), announced that it has completed the acquisition of Straub Medical AG, a privately-held company that develops and sells medical atherectomy and thrombectomy devices that treat peripheral arterial disease (PAD) and venous disease. BD welcomes more than 80 new associates who add valuable experience and expertise as well as key technologies.

Key Market Segments: Atherectomy Devices Market

Market by Product, 2020-2029, (USD Billion), (Thousand Units).

• Directional
• Rotational
• Laser
• Orbital

Market by End User, 2020-2029, (USD Billion), (Thousand Units).

• Hospitals
• Surgical Centers
• Ambulatory Care Centers
• Research Laboratories
• Academic Institutes

Market by Application, 2020-2029, (USD Billion), (Thousand Units).

• Peripheral Vascular
• Cardiovascular
• Neurovascular

Market by Region, 2020-2029, (USD Billion), (Thousand Units).

• North America
• Asia Pacific
• Europe
• South America

The post Procedural Complexity and learning curve associated with atherectomy procedures act as a restraint in the atherectomy devices market appeared first on Exactitude Consultancy.